We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current EXAS market cap is 7.8B. The company's latest EPS is USD -1.1246 and P/E is -38.17.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 602.45M | 622.09M | 700.37M | 653.29M | 637.52M |
| Operating Income | -77.02M | -76.38M | 6.85M | -67.84M | -102.25M |
| Net Income | -74.15M | -81.03M | 794k | -49.77M | -110.23M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 876.29M | 1.49B | 1.77B | 2.08B | 2.58B |
| Operating Income | -233.78M | -791.68M | -855.68M | -593.51M | -214.39M |
| Net Income | -83.99M | -848.53M | -595.63M | -623.51M | -204.15M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.3B | 6.36B | 6.42B | 6.47B | 6.38B |
| Total Liabilities | 3.25B | 3.3B | 3.3B | 3.33B | 3.24B |
| Total Equity | 3.06B | 3.06B | 3.12B | 3.15B | 3.13B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.51B | 4.93B | 6.68B | 6.23B | 6.47B |
| Total Liabilities | 1.22B | 2.1B | 3.3B | 3.18B | 3.33B |
| Total Equity | 2.29B | 2.82B | 3.39B | 3.04B | 3.15B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -38.22M | 62.21M | 86.57M | 156.12M | -82.31M |
| Investing | 82.94M | 149.42M | 116.45M | 49.68M | -171.44M |
| Financing | 133.6M | 149.64M | 149.73M | 159.77M | -3M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -115.01M | 136.48M | -102.24M | -223.56M | 156.12M |
| Investing | -121.07M | -702.04M | -1.08B | 74.07M | 49.68M |
| Financing | 253.18M | 1.88B | 8.47M | 76.49M | 159.77M |
| Market Cap | 7.8B |
| Price to Earnings Ratio | -38.17 |
| Price to Sales Ratio | 3.02 |
| Price to Cash Ratio | 12.87 |
| Price to Book Ratio | 2.48 |
| Dividend Yield | - |
| Shares Outstanding | 181.53M |
| Average Volume (1 week) | 2.09M |
| Average Volume (1 Month) | 3.46M |
| 52 Week Change | -50.03% |
| 52 Week High | 100.77 |
| 52 Week Low | 42.72 |
| Spread (Intraday) | 1.22 (2.78%) |
| Company Name | EXACT Sciences Corporation |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.exactsciences.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
